期刊文献+

转染pCE质粒的干细胞对肝癌治疗的影响

Effect of Transfected Stem Cells with pCE Plasmid on Therapy for Liver Cancer
下载PDF
导出
摘要 目的观察转染pCE质粒的干细胞对肝癌的治疗作用。方法采用尾静脉直接注射法治疗大鼠肝脏转移瘤,设立阴性对照、干细胞、转染pCE质粒的干细胞组和5-Fu组,通过观察转移瘤在肝脏组织中的生长情况和卫星灶形成,肝脏组织的病理学改变,检测基质衍生因子-1(stromal cell de-rived factor-1,SDF-1)表达,比较4组对肝癌的治疗作用。结果转染pCE质粒的干细胞组对肿瘤细胞的生长抑制率(56%)与阴性对照组(0)、干细胞组(8%)和5-Fu组(78%)比较差异有统计学意义(P<0.05)。治疗前4组SDF-1的表达差异无统计学意义(P>0.05)。转染pCE质粒的干细胞组SDF-1在治疗后分泌增加(OD=0.48),与阴性对照组(OD=0.35)、干细胞组(OD=0.39)和5-Fu组(OD=0.36)比较差异有统计学意义(P<0.05)。结论转染pCE质粒的干细胞有抑制肝癌生长的作用,SDF-1表达水平上升是其机制之一。 Objective To observe stem cells with pCE plasmid therapy for liver cancer,and explore its related mechanism.Methods After injection of stem cells into tail vein,inhibiting tumor ratio was calculated,satellite lesions in the liver,change of tumor mass in pathology,expression of SDF-1 were studied.The difference among control group,group of stem cells,group of stem cells with pCE plasmid,and group of 5-Fu were compared.Results Stem cells with pCE plasmid could inhibit proliferation of cancer cells (56%)in the following 10 day(P0.05),compared with control group(0%),group of stem cells(8%) and group of 5-Fu(78%),respectively.Expression of SDF-1 from group of stem cells with pCE plasmid after treatment was increased (OD=0.48),different from control group(OD=0.35),group of stem cells(OD=0.39) and group of 5-Fu(OD=0.36) (P0.05).Expression of SDF-1 from all groups before treatment did not have difference(P0.05).Conclusion Stem cells with pCE plasmid could inhibit proliferation of cancer cells through the help of SDF-1.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2010年第12期1370-1373,共4页 Cancer Research on Prevention and Treatment
基金 武汉市科技局晨光计划科研基金资助项目(200750731292)
关键词 基因治疗 干细胞 肝肿瘤 趋化因子CXCL12 Gene therapy Stem cells Liver neoplasms Chemokine CXCL12
  • 相关文献

参考文献16

  • 1Schwartz RE, Reyes M, Koodie I., et al. Muhipotent adult progenitor cells from bone marrow differentiate into functional bepatocyte-like cells[J]. J Clin Invest, 2002, 109(10):1291- 1302. 被引量:1
  • 2Theise ND, Nimmakayalu M, Gardner R, et al. Liver from bone marrow in humans [J]. Hepatology, 2000, 32 ( 1 ) : 11- 16. 被引量:1
  • 3Terai S, Sakaida I, Yamamoto N, et al. An in vivo model for monitoring trans-differentiation of bone marrow cells into 5- Functional hepatocytes[J]. J Biochem, 21103, 134(4): 551- 558. 被引量:1
  • 4Hamada H, Kobune M, Nakamura K, et al. Mesenchyrnal stem cells (MSC) as therapeutic cytoreagents for gene therapy [J]. Cancer Sci, 2(105, 96(3): 149-156. 被引量:1
  • 5Kollet O, Shivtiel S, Chen YO, et al. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34 + stem cell recruitment to the liver[J]. J Clin Invest, 2003, 112 (2) : 160- 169. 被引量:1
  • 6Kucia M, Wojakowski W, Reca R, et al. The migration of bone marrow derived non-hematopoietic tissue-committed stem cells is regulated in an SDF-I-, HGF , and LIF-dependent manner[J]. Arch Immunol Ther Exp (Warsz). 2006, 54 ( 2 ) : 121-135. 被引量:1
  • 7Suratt BT. Petty JM, Young SK, et al. Role of the CXCR4 SDF-1 chemokine axis m circulating neutrophil homeostasis[J]. Blood, 2004. 104(2): 565-571. 被引量:1
  • 8Lataillade JJ, Clay D, Dupuy C. et al. Chemokine SDF-1 en hances circulating CD34 + cell proliferation in syncrgy with cytokines: possible role in progenitor survival[J]. Blood, 2000, 95(3): 756-768. 被引量:1
  • 9N. I.amerant-Fayeh C. da Crola Silva and C. Kieda. Tumor and Host Endothelial Cell Selective Interactions and Modulation by Microenvironmental Chemokines: Tumor Endothelial Cell Cross Talk Specificity[J]. Cancer Growth and Progression,2005, 15(0): 219-231. 被引量:1
  • 10Jin H, Su J. Garmy-Susini B. et al. Integrinα4β1 promotes monocyte trafficking and angioplasmidsis in tumors[J]. Cancer Res. 20(16. 66(4): 2146-2152. 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部